# Glyphic Biotechnologies, Inc.

Canonical: https://abierto.us/vendors/glyphic-biotechnologies-inc-f57wt7jzdh19

- UEI: F57WT7JZDH19
- CAGE: 94M19
- Location: New York, NY
- Awards in window: 1 (1 transactions), $249,993 obligated, April 8, 2024 to April 8, 2024

## Awarding agencies

- Defense Health Agency: 1 awards, $249,993

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $249,993

## Competition

- Full and Open Competition After Exclusion of Sources: 1 awards

## Largest awards

- HT942524P0042 (purchase order): $249,993, Army Med Res Acq Activity. Medical R and D Purchase Order for a DHA STTR Phase I, Proposal No. H23C-001-0042, Titled, "development of Anti-Glycan Antibodies Against Multi-Drug Resistant Eskape Wound Pathogens". https://www.usaspending.gov/award/CONT_AWD_HT942524P0042_9700_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/glyphic-biotechnologies-inc-f57wt7jzdh19.